Publications

Articles

Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: an open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics

(2018). Pediatr Diabetes., E published ahead of print. http://dx.doi.org/10.1111/pedi.12660, PMID: 29473705

Weir GC1, Ehlers MR2, Harris KM3, Kanaparthi S3, Long A4, Phippard D3, Weiner LJ5, Jepson B5, McNamara JG6, Koulmanda M7, Strom TB7; ITN RETAIN Study Team.

[PubMed] [Citation View]

Weir GC1, Ehlers MR2, Harris KM3, Kanaparthi S3, Long A4, Phippard D3, Weiner LJ5, Jepson B5, McNamara JG6, Koulmanda M7, Strom TB7; ITN RETAIN Study Team. (2018). Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: an open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatr Diabetes., E published ahead of print. http://dx.doi.org/10.1111/pedi.12660, PMID: 29473705

Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R

(2017). Hepatology, 65 (2), 647-60. http://dx.doi.org/10.1002/hep.28681, PMID: 27302659, PMCID: PMC5159322

Feng S, Demetris AJ, Kanaparthi S, Ekong UD, Alonso EM, Rosenthal P, Turka LA, Ikle D, Tchao NK, Spain KM, Burrell BE

Publications

Articles

Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: an open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics

Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R

ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis

Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab Determine Body Composition Changes during Induction Treatment of ANCA-Associated Vasculitis

An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection

The pharmacogenomic association of Fcγ receptors and cytochrome p450 enzymes and response to treatment with rituximab or cyclophosphamide in Anti-Neutrophil Cytoplasmic Antibody-Associated vasculitis

Association of serum calprotectin (S100A8/S100A9) levels with disease relapses in PR3-ANCA-associated vasculitis

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial

Anti-Gal and anti-Neu5Gc responses in nonimmunosuppressed patients following treatment with rabbit anti-thymocyte polyclonal IgGs

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis

B Cell Receptor Genes Associated with Tolerance Identify a Cohort of Immunosuppressed Patients with Improved Renal Allograft Graft Function

Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance

Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index

A composite score associated with spontaneous operational tolerance in kidney transplant recipients

Effects of Omalizumab on Rhinovirus Infections, Illnesses and Exacerbations of Asthma

Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes

Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 Diabetes

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis

Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

The allergen-specificity of early peanut consumption and the impact on the development of allergic disease in the LEAP Study Cohort

LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction

Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation

Synchronous Immune Alterations Mirror Clinical Response During Allergen Immunotherapy

Food Allergy: Update on Prevention and Tolerance

Food Allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention and management

Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States

Changes in T-cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes

Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice

Effect of Avoidance on Peanut Allergy after Early Peanut Consumption

Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial

Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial

Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes

A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins

Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers

Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report

Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients

Randomized trial of peanut consumption in infants at risk for peanut allergy

Peripheral CD5+ B-cells in antineutrophil cytoplasmic antibody-associated vasculitis

Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals